News
- - News
Entertainment
- - Funny & Gags
  - Gossip
Business
- - Business
Sports
- - Sports
Science & Tech
- - Tech
  - Science

AstraZeneca Pharma gains 3% on plan to launch cancer drug in India

News / News 7 years ago 558 Views comments

Osimertinib is an oral anti-cancer drug for management of lung cancer.

Source:
Moneycontrol Latest News

facebook
twitter
Whatsapp
google+
linkedin
email

Paid Prime Membership on Primevideo.com

Previous post

Westlife Development#39;s board meeting on August 01, 2017

Next post

Stay with winners! Top 12 wealth creators across sectors for a period of 2-3 years

Comments

Related Posts

Challenge lies in IBC#39;s successful implementation: SC judge

News / News - 7 years ago

Indian ADRs: Dr Reddy#39;s Lab down 3.3%, Tata Motors slips 2%

News / News - 7 years ago

DATA STORY: 12 Years a Chancellor, Angela Merkel takes the helm in Germany again

News / News - 7 years ago

Pharma weekly wrap: Pharma stocks had tough week due to GST and pricing pressures in US

News / News - 7 years ago

Demonetisation details: RBI still assessing quantum of returned old notes

News / News - 7 years ago

Buy Ashok Leyland; target of Rs 122: Motilal Oswal

News / News - 7 years ago

RIVER Collection launch: Latest styles from your favourite designers | Made for Amazon | Up to 20% off - Launching on 1st

Follow @truearacom

TrueAra

Pages

Popular Tweets
Privacy
Terms Of Use

Categories

Living
Movies

Follow us

Copyright 2016-2017 Content Aggregator All rights reserved.

No results found.

Home
News
- News
Entertainment
- Funny & Gags
- Gossip
Business
- Business
Sports
- Sports
Science & Tech
- Tech
- Science